Medtecs International Corporation Ltd
SGX:546
Balance Sheet
Balance Sheet Decomposition
Medtecs International Corporation Ltd
Current Assets | 95.8m |
Cash & Short-Term Investments | 33m |
Receivables | 20.1m |
Other Current Assets | 42.7m |
Non-Current Assets | 71m |
Long-Term Investments | 2.5m |
PP&E | 53.6m |
Intangibles | 3.4m |
Other Non-Current Assets | 11.5m |
Current Liabilities | 33m |
Accounts Payable | 6m |
Short-Term Debt | 23.9m |
Other Current Liabilities | 3.1m |
Non-Current Liabilities | 4.6m |
Long-Term Debt | 2.2m |
Other Non-Current Liabilities | 2.4m |
Balance Sheet
Medtecs International Corporation Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1
|
2
|
2
|
2
|
5
|
3
|
82
|
49
|
18
|
15
|
|
Cash |
1
|
2
|
2
|
2
|
5
|
3
|
82
|
49
|
18
|
15
|
|
Short-Term Investments |
3
|
2
|
2
|
3
|
4
|
5
|
5
|
10
|
26
|
20
|
|
Total Receivables |
13
|
14
|
14
|
15
|
15
|
13
|
49
|
47
|
32
|
20
|
|
Accounts Receivables |
13
|
14
|
14
|
15
|
15
|
13
|
49
|
42
|
30
|
19
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
1
|
|
Inventory |
37
|
36
|
35
|
34
|
34
|
38
|
54
|
50
|
36
|
37
|
|
Other Current Assets |
13
|
16
|
15
|
17
|
17
|
16
|
16
|
8
|
4
|
3
|
|
Total Current Assets |
66
|
69
|
67
|
71
|
74
|
75
|
206
|
163
|
110
|
96
|
|
PP&E Net |
33
|
30
|
30
|
29
|
28
|
31
|
31
|
45
|
58
|
54
|
|
PP&E Gross |
33
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
58
|
54
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
53
|
51
|
55
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
Goodwill |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
Long-Term Investments |
4
|
4
|
3
|
3
|
3
|
3
|
3
|
5
|
9
|
6
|
|
Other Long-Term Assets |
1
|
5
|
4
|
6
|
7
|
7
|
5
|
2
|
4
|
4
|
|
Other Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Total Assets |
105
N/A
|
109
+4%
|
106
-3%
|
110
+4%
|
113
+3%
|
117
+3%
|
246
+111%
|
216
-12%
|
182
-16%
|
167
-8%
|
|
Liabilities | |||||||||||
Accounts Payable |
13
|
15
|
9
|
8
|
7
|
4
|
10
|
5
|
2
|
10
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
|
Short-Term Debt |
1
|
0
|
30
|
33
|
33
|
36
|
32
|
9
|
16
|
24
|
|
Current Portion of Long-Term Debt |
29
|
29
|
1
|
1
|
2
|
0
|
1
|
1
|
1
|
1
|
|
Other Current Liabilities |
0
|
1
|
2
|
1
|
1
|
1
|
3
|
4
|
5
|
4
|
|
Total Current Liabilities |
43
|
46
|
43
|
44
|
43
|
41
|
46
|
21
|
25
|
33
|
|
Long-Term Debt |
4
|
2
|
0
|
2
|
6
|
9
|
3
|
6
|
3
|
2
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Minority Interest |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
1
|
|
Other Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
|
Total Liabilities |
49
N/A
|
50
+1%
|
45
-10%
|
48
+6%
|
51
+6%
|
53
+5%
|
52
-2%
|
30
-42%
|
32
+6%
|
38
+16%
|
|
Equity | |||||||||||
Common Stock |
23
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
27
|
|
Retained Earnings |
26
|
27
|
28
|
29
|
30
|
31
|
158
|
153
|
121
|
100
|
|
Additional Paid In Capital |
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
|
Other Equity |
1
|
0
|
1
|
1
|
0
|
0
|
3
|
2
|
1
|
1
|
|
Total Equity |
55
N/A
|
59
+8%
|
61
+2%
|
62
+2%
|
62
+1%
|
64
+2%
|
193
+204%
|
185
-4%
|
150
-19%
|
129
-14%
|
|
Total Liabilities & Equity |
105
N/A
|
109
+4%
|
106
-3%
|
110
+4%
|
113
+3%
|
117
+3%
|
246
+111%
|
216
-12%
|
182
-16%
|
167
-8%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
468
|
549
|
0
|
549
|
549
|
549
|
549
|
546
|
545
|
545
|